198 related articles for article (PubMed ID: 36107988)
1. Skeletal muscle contraction kinetics and AMPK responses are modulated by the adenine nucleotide degrading enzyme AMPD1.
Hafen PS; Law AS; Matias C; Miller SG; Brault JJ
J Appl Physiol (1985); 2022 Nov; 133(5):1055-1066. PubMed ID: 36107988
[TBL] [Abstract][Full Text] [Related]
2. Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle.
Plaideau C; Lai YC; Kviklyte S; Zanou N; Löfgren L; Andersén H; Vertommen D; Gailly P; Hue L; Bohlooly-Y M; Hallén S; Rider MH
Chem Biol; 2014 Nov; 21(11):1497-1510. PubMed ID: 25459662
[TBL] [Abstract][Full Text] [Related]
3. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
4. Effects of genetic deletion of soluble 5'-nucleotidases NT5C1A and NT5C2 on AMPK activation and nucleotide levels in contracting mouse skeletal muscles.
Kviklyte S; Vertommen D; Yerna X; Andersén H; Xu X; Gailly P; Bohlooly-Y M; Oscarsson J; Rider MH
Am J Physiol Endocrinol Metab; 2017 Jul; 313(1):E48-E62. PubMed ID: 28325731
[TBL] [Abstract][Full Text] [Related]
5. Protecting the cellular energy state during contractions: role of AMP deaminase.
Hancock CR; Brault JJ; Terjung RL
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():17-29. PubMed ID: 17242488
[TBL] [Abstract][Full Text] [Related]
6. AMP deamination is sufficient to replicate an atrophy-like metabolic phenotype in skeletal muscle.
Miller SG; Hafen PS; Law AS; Springer CB; Logsdon DL; O'Connell TM; Witczak CA; Brault JJ
Metabolism; 2021 Oct; 123():154864. PubMed ID: 34400216
[TBL] [Abstract][Full Text] [Related]
7. AMPD1: a novel therapeutic target for reversing insulin resistance.
Cheng J; Morisaki H; Toyama K; Sugimoto N; Shintani T; Tandelilin A; Hirase T; Holmes EW; Morisaki T
BMC Endocr Disord; 2014 Dec; 14():96. PubMed ID: 25511531
[TBL] [Abstract][Full Text] [Related]
8. Adenine nucleotide depletion in human muscle during exercise: causality and significance of AMP deamination.
Sahlin K; Broberg S
Int J Sports Med; 1990 May; 11 Suppl 2():S62-7. PubMed ID: 2361781
[TBL] [Abstract][Full Text] [Related]
9. Adaptation of rat skeletal muscle to creatine depletion: AMP deaminase and AMP deamination.
Ren JM; Holloszy JO
J Appl Physiol (1985); 1992 Dec; 73(6):2713-6. PubMed ID: 1490990
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of AMP-metabolizing enzymes controls adenine nucleotide levels and AMPK activation in HEK293T cells.
Plaideau C; Liu J; Hartleib-Geschwindner J; Bastin-Coyette L; Bontemps F; Oscarsson J; Hue L; Rider MH
FASEB J; 2012 Jun; 26(6):2685-94. PubMed ID: 22415305
[TBL] [Abstract][Full Text] [Related]
11. [AMPD genes and urate metabolism].
Morisaki H; Morisaki T
Nihon Rinsho; 2008 Apr; 66(4):771-7. PubMed ID: 18409530
[TBL] [Abstract][Full Text] [Related]
12. Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle.
Davis PR; Miller SG; Verhoeven NA; Morgan JS; Tulis DA; Witczak CA; Brault JJ
Metabolism; 2020 Jul; 108():154257. PubMed ID: 32370945
[TBL] [Abstract][Full Text] [Related]
13. Influence of acidosis on AMP deaminase activity in contracting fast-twitch muscle.
Dudley GA; Terjung RL
Am J Physiol; 1985 Jan; 248(1 Pt 1):C43-50. PubMed ID: 3966542
[TBL] [Abstract][Full Text] [Related]
14. Changes in contraction-induced phosphorylation of AMP-activated protein kinase and mitogen-activated protein kinases in skeletal muscle after ovariectomy.
Wohlers LM; Sweeney SM; Ward CW; Lovering RM; Spangenburg EE
J Cell Biochem; 2009 May; 107(1):171-8. PubMed ID: 19259949
[TBL] [Abstract][Full Text] [Related]
15. A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles.
Piette AB; Dufresne SS; Frenette J
BMC Musculoskelet Disord; 2016 Oct; 17(1):449. PubMed ID: 27793139
[TBL] [Abstract][Full Text] [Related]
16. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction.
Jensen TE; Rose AJ; Jørgensen SB; Brandt N; Schjerling P; Wojtaszewski JF; Richter EA
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1308-17. PubMed ID: 17213473
[TBL] [Abstract][Full Text] [Related]
17. Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice.
Hancock CR; Janssen E; Terjung RL
J Appl Physiol (1985); 2006 Feb; 100(2):406-13. PubMed ID: 16195390
[TBL] [Abstract][Full Text] [Related]
18. Alterations in AMP deaminase activity and kinetics in skeletal muscle of creatine kinase-deficient mice.
Tullson PC; Rush JW; Wieringa B; Terjung RL
Am J Physiol; 1998 May; 274(5):C1411-6. PubMed ID: 9612229
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle contractile performance and ADP accumulation in adenylate kinase-deficient mice.
Hancock CR; Janssen E; Terjung RL
Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1287-97. PubMed ID: 15659712
[TBL] [Abstract][Full Text] [Related]
20. Low-intensity contraction activates the alpha1-isoform of 5'-AMP-activated protein kinase in rat skeletal muscle.
Toyoda T; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Sato K; Fushiki T; Nakao K; Hayashi T
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E583-90. PubMed ID: 16249251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
